Astragaloside IV protects against podocyte apoptosis by inhibiting oxidative stress via activating PPARγ-Klotho-FoxO1 axis in diabetic nephropathy

  • Life Sci. 2021 Mar 15;269:119068. doi: 10.1016/j.lfs.2021.119068.
Lina Xing  1 Ji Fang  1 Bingbing Zhu  1 Li Wang  2 Junliang Chen  1 Yunman Wang  1 Jiebo Huang  1 Hao Wang  3 Xingmei Yao  4
Affiliations
  • 1. Department of Nephrology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200062, China.
  • 2. Laboratory of Renal Disease, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200062, China.
  • 3. Department of Nephrology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200062, China. Electronic address: [email protected].
  • 4. Department of Nephrology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200062, China. Electronic address: [email protected].
Abstract

Aims: Podocyte Apoptosis plays an important role in the pathogenesis of diabetic nephropathy (DN). Astragaloside IV (AS-IV) has been shown to protect against podocyte Apoptosis. Here we aim to investigate the mechanism responsible for the protective effects of AS-IV.

Main methods: Diabetic db/db mice and high glucose (HG)-cultured podocytes were treated with AS-IV. Renal function and histopathological changes were measured to evaluate the therapeutic effects of AS-IV against DN. Adenovirus-mediated Klotho overexpression, Klotho siRNA, and PPARγ Inhibitor were applied in vitro to investigate the potential mechanism. The expression levels of mRNA and proteins were analyzed by qRT-PCR, western blot or immunofluorescence. Intracellular ROS and mitochondrial superoxide were detected by DHE and MitoSOx Red, respectively. Cell Apoptosis was evaluated by TUNEL staining and flow cytometry.

Key findings: AS-IV improved renal function and ameliorated podocyte injury in db/db mice accompanied with enhanced Klotho expression in glomerular podocytes. In vitro, AS-IV inhibited HG-induced podocyte Apoptosis and restored HG-inhibited Klotho expression, whereas Klotho knockdown abrogated the anti-apoptosis action of AS-IV. Further study showed that adenovirus-mediated Klotho overexpression enhanced Forkhead transcription factor O1 (FOXO1)-dependent antioxidant activity and attenuated HG-evoked oxidative stress and Apoptosis. AS-IV prevented HG-induced FOXO1 inhibition and oxidative stress, whereas Klotho knockdown reversed these effects. Cotreatment with PPARγ Inhibitor T0070907 abolished AS-IV-induced Klotho expression and anti-apoptosis action.

Significance: These data suggested that AS-IV attenuated podocyte Apoptosis presumably by inhibiting oxidative stress via activating PPARγ-Klotho-FoxO1 signaling pathway, thereby ameliorating DN. This study provided new insights into the molecular mechanisms of AS-IV against DN.

Keywords
Astragaloside IV; Diabetic nephropathy; FoxO1; Klotho; PPARγ; Podocyte apoptosis.
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • 99.98%, PPARγ Antagonist
    target: PPAR
    Research Areas: Cancer